Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada

BACKGROUND: Public drug insurance plans provide limited reimbursement for Alzheimer's disease (AD) medications in many jurisdictions, including Canada and the United Kingdom. This study was conducted to assess Canadians' level of support for an increase in annual personal income taxes to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Oremus, Mark, Tarride, Jean-Eric, Clayton, Natasha, Raina, Parminder
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806272/
https://www.ncbi.nlm.nih.gov/pubmed/20040110
http://dx.doi.org/10.1186/1472-6963-9-246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806272/
https://www.ncbi.nlm.nih.gov/pubmed/20040110
http://dx.doi.org/10.1186/1472-6963-9-246

Ejemplares similares